TScan Therapeutics
TCRX
TCRX
80 hedge funds and large institutions have $242M invested in TScan Therapeutics in 2024 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 19 increasing their positions, 14 reducing their positions, and 16 closing their positions.
Holders
80
Holders Change
+14
Holders Change %
+21.21%
% of All Funds
1.16%
Holding in Top 10
4
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.06%
New
31
Increased
19
Reduced
14
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
1
BlackRock
New York
|
$26.1M |
2 |
GPP
2
Great Point Partners
Greenwich,
Connecticut
|
$5.5M |
3 |
SC
3
Stempoint Capital
New York
|
$4.94M |
4 |
LP
4
LMR Partners
London,
United Kingdom
|
$3.89M |
5 |
![]()
5
Adage Capital Partners
Boston,
Massachusetts
|
$25.7M |